Literature DB >> 8885291

Characterization of the metabotropic glutamate receptors (mGluRs) which modulate GABA-mediated inhibition in the ventrobasal thalamus.

T E Salt1, S A Eaton, J P Turner.   

Abstract

The ventrobasal thalamus (VB) relays and processes somatosensory information ascending to the cerebral cortex. Several types of mGluR are known to be present in VB, and we have previously shown that Group II and Group III mGluR agonists can reduce inhibitory synaptic transmission by acting at presynaptic receptors on GABAergic terminals in this structure. We have tested the action of several antagonists against the disinhibitory action of the Group II agonist CCG-I [(2S,3S,4S)-alpha-(carboxycyclopropyl)-glycine] and the Group III agonist L-AP4 [L-2-amino-4-phosphonobutyrate] in the VB of anaesthetized rats using extracellular single-neurone recording techniques and iontophoretic applications of mGluR antagonists and agonists. The antagonists MAP4 [alpha-methyl-L-AP4] and MPPG [(+/-)-alpha-methyl-4-phosphonophenylglycine] reduced the disinhibitory actions of L-AP4 whilst having little effect on the disinhibitory action of CCG-I. In contrast, MCCG [alpha-methyl-CCG-I] and MCPG [(+)-alpha-methyl-4-carboxyphenylglycine] antagonized CCG-I, whilst having less effect against L-AP4 responses. These results support the hypothesis that GABAergic inhibitory transmission in VB can be modulated by at least two types of mGluR, belonging to Group II and Group III. Furthermore, the novel antagonists appear to be useful tools for the future study of the physiological role of these receptors in thalamic sensory processing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8885291     DOI: 10.1016/0197-0186(95)00146-8

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  Modulation of absence seizures by the GABA(A) receptor: a critical rolefor metabotropic glutamate receptor 4 (mGluR4).

Authors:  O C Snead; P K Banerjee; M Burnham; D Hampson
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Positive allosteric modulation reveals a specific role for mGlu2 receptors in sensory processing in the thalamus.

Authors:  C S Copeland; S A Neale; T E Salt
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

3.  Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing.

Authors:  E Palazzos; V de Novellis; I Marabese; F Rossi; S Maione
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

4.  Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study.

Authors:  R C Roberts; J K Roche; R E McCullumsmith
Journal:  Neuroscience       Date:  2014-07-24       Impact factor: 3.590

Review 5.  Glutamate and Its Receptors as Therapeutic Targets for Migraine.

Authors:  Jan Hoffmann; Andrew Charles
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

6.  Update on the neurobiology of schizophrenia: a role for extracellular microdomains.

Authors:  D Shan; S Yates; R C Roberts; R E McCullumsmith
Journal:  Minerva Psichiatr       Date:  2012-09-01

Review 7.  Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate.

Authors:  Mikael Angehagen; Elinor Ben-Menachem; Lars Rönnbäck; Elisabeth Hansson
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

8.  Enhanced group II mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala.

Authors:  Jeong S Han; Yu Fu; Gary C Bird; Volker Neugebauer
Journal:  Mol Pain       Date:  2006-05-08       Impact factor: 3.395

9.  Neuronal activity patterns in the mediodorsal thalamus and related cognitive circuits are modulated by metabotropic glutamate receptors.

Authors:  C S Copeland; S A Neale; T E Salt
Journal:  Neuropharmacology       Date:  2015-01-07       Impact factor: 5.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.